Debt-to-equity of Roivant Sciences Ltd. from 31 Dec 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Roivant Sciences Ltd. quarterly Debt-to-equity in % history and change rate from 31 Dec 2021 to 31 Dec 2025.
  • Roivant Sciences Ltd. Debt-to-equity for the quarter ending 31 Dec 2025 was 5.5%, a 47% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Roivant Sciences Ltd. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 5.5% -4.9% -47% 31 Dec 2025
Q3 2025 5.3% -6.8% -56% 30 Sep 2025
Q2 2025 7% -8.5% -55% 30 Jun 2025
Q1 2025 8.5% -13% -61% 31 Mar 2025
Q4 2024 10% -23% -69% 31 Dec 2024
Q3 2024 12% -66% -85% 30 Sep 2024
Q2 2024 15% -58% -79% 30 Jun 2024
Q1 2024 22% -44% -67% 31 Mar 2024
Q4 2023 34% -21% -39% 31 Dec 2023
Q3 2023 78% +36% +84% 30 Sep 2023
Q2 2023 73% +37% +101% 30 Jun 2023
Q1 2023 66% +36% +121% 31 Mar 2023
Q4 2022 55% +25% +86% 31 Dec 2022
Q3 2022 42% 30 Sep 2022
Q2 2022 36% 30 Jun 2022
Q1 2022 30% 31 Mar 2022
Q4 2021 29% 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.